pubmed-article:15735124 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15735124 | lifeskim:mentions | umls-concept:C0029463 | lld:lifeskim |
pubmed-article:15735124 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
pubmed-article:15735124 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:15735124 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
pubmed-article:15735124 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
pubmed-article:15735124 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
pubmed-article:15735124 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:15735124 | pubmed:dateCreated | 2005-2-28 | lld:pubmed |
pubmed-article:15735124 | pubmed:abstractText | Mutations of the TP53 gene have been associated with resistance to chemotherapy as well as poor prognosis in many different malignancies. This is the first prospective study of the prognostic value of somatic TP53 mutations in patients with newly diagnosed extremity osteosarcoma. | lld:pubmed |
pubmed-article:15735124 | pubmed:language | eng | lld:pubmed |
pubmed-article:15735124 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15735124 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15735124 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15735124 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15735124 | pubmed:month | Mar | lld:pubmed |
pubmed-article:15735124 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:ManghamD CDC | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:AndrulisIrene... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:BullShelley... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:GHIGIEE | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:ParkesRobertR | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:RockMichael... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:GokgozNalanN | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:BellRobert... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:WunderJay SJS | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:MalkinDavidD | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:GrimerRobert... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:DavisAileen... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:ConradErnest... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:EskandarianSa... | lld:pubmed |
pubmed-article:15735124 | pubmed:author | pubmed-author:BeauchampChri... | lld:pubmed |
pubmed-article:15735124 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15735124 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15735124 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:15735124 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15735124 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15735124 | pubmed:pagination | 1483-90 | lld:pubmed |
pubmed-article:15735124 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:meshHeading | pubmed-meshheading:15735124... | lld:pubmed |
pubmed-article:15735124 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15735124 | pubmed:articleTitle | TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study. | lld:pubmed |
pubmed-article:15735124 | pubmed:affiliation | Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. wunder@mshri.on.ca | lld:pubmed |
pubmed-article:15735124 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15735124 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15735124 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15735124 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15735124 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15735124 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15735124 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15735124 | lld:pubmed |